FI20020807A0 - Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita - Google Patents

Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita

Info

Publication number
FI20020807A0
FI20020807A0 FI20020807A FI20020807A FI20020807A0 FI 20020807 A0 FI20020807 A0 FI 20020807A0 FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A0 FI20020807 A0 FI 20020807A0
Authority
FI
Finland
Prior art keywords
vap
monoclonal antibodies
humanized anti
novel humanized
novel
Prior art date
Application number
FI20020807A
Other languages
English (en)
Swedish (sv)
Inventor
Sirpa Jalkanen
Marko Salmi
Marja-Leena Laukkanen
Michael Ronald Clark
Original Assignee
Biotie Therapies Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Oyj filed Critical Biotie Therapies Oyj
Priority to FI20020807A priority Critical patent/FI20020807A0/fi
Publication of FI20020807A0 publication Critical patent/FI20020807A0/fi
Priority to PCT/FI2003/000330 priority patent/WO2003093319A1/en
Priority to AU2003229799A priority patent/AU2003229799A1/en

Links

FI20020807A 2002-04-29 2002-04-29 Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita FI20020807A0 (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20020807A FI20020807A0 (fi) 2002-04-29 2002-04-29 Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
PCT/FI2003/000330 WO2003093319A1 (en) 2002-04-29 2003-04-28 Novel humanized anti-vap-1 monoclonal antibody
AU2003229799A AU2003229799A1 (en) 2002-04-29 2003-04-28 Novel humanized anti-vap-1 monoclonal antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020807A FI20020807A0 (fi) 2002-04-29 2002-04-29 Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita

Publications (1)

Publication Number Publication Date
FI20020807A0 true FI20020807A0 (fi) 2002-04-29

Family

ID=8563846

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020807A FI20020807A0 (fi) 2002-04-29 2002-04-29 Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita

Country Status (3)

Country Link
AU (1) AU2003229799A1 (fi)
FI (1) FI20020807A0 (fi)
WO (1) WO2003093319A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20050574A0 (fi) * 2005-05-31 2005-05-31 Faron Pharmaceuticals Oy Koostumuksia, jotka kohdistuvat amiinioksidaaseihin in vivo
FI20075278A0 (fi) * 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
UA112154C2 (uk) 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
US20160113893A1 (en) 2013-06-12 2016-04-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
EP3386494A1 (en) 2015-12-07 2018-10-17 Benevolentai Cambridge Limited Vap-1 inhibitors for treating pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656906B1 (en) * 1992-06-09 1999-09-08 Oy Biotie Therapies A novel endothelial cell molecule mediating lymphocyte binding in man
CA2289903A1 (en) * 1997-05-23 1998-11-26 Oy Biotie Therapies, Ltd. Vascular adhesion protein-1 having amine oxidase activity
GB9809951D0 (en) * 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules

Also Published As

Publication number Publication date
WO2003093319A1 (en) 2003-11-13
AU2003229799A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
DK1501856T3 (da) Anti-HER2 antistofvarianter
NO20054351D0 (no) Monoklonalt antistoff og hybridom som produserer dette
EE200300179A (et) Humaniseeritud LT-ß-R-i vastased antikehad
AU2003264009A8 (en) Humanized rabbit antibodies
DK1478667T3 (da) Monoklonalt anti-humant tenascin-antistof
NO20044347L (no) Anti-alfavbeta6-antistoff
EP1761566A4 (en) HUMANIZED MONOCLONAL ANTIBODIES ANTI-TAG-72
IL191217A (en) Anti-17 mantle monoclonal antibody
DK1599504T3 (da) Modificeret antistof
IS6982A (is) Mótefni gegn VLA-1
ATE549033T1 (de) Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper
EP1567555A4 (en) HUMANIZED ANTIBODIES AGAINST CHEMOTOXIC MONOCYTE PROTEINS
BRPI0509495A2 (pt) anticorpo humanizado
EE200300569A (et) CD44v6-spetsiifilised antikehad
FI20020807A0 (fi) Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
NO20044145L (no) Assay for anti-INGAP antistoffer
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
EP1712564A4 (en) MONOCLONAL ANTIBODY ANTI-NC1
DE112004002660D2 (de) Humaner monoklonaler Antikörper mit fettsenkender Wirkung
ATE535259T1 (de) Immunogener, monoklonaler antikörper
DE60239895D1 (de) Humanisierte super-antikörper
IL165753A0 (en) Humanized monoclonal antibody nPAM4
AU2003236346A1 (en) Monoclonal antibody neutralizing megsin